Core Viewpoint - The company has announced a share buyback plan totaling up to HKD 10 billion, in addition to a completed buyback of HKD 3.87 billion, indicating a strong commitment to returning value to shareholders [1] Group 1: Share Buyback Details - The company completed a share buyback of HKD 3.87 billion in the first half of 2024 [1] - The board has approved an additional share buyback plan of up to HKD 10 billion [1] - As of September 19, approximately HKD 7.73 billion has been utilized to repurchase a total of about 164 million shares [1] Group 2: Future Buyback Plans - Starting from September 19, the company plans to repurchase up to HKD 50 billion in shares over the next 24 months, excluding the previously mentioned HKD 10 billion [1] - The repurchased shares will be canceled [1]
石药集团已完成 3.87 亿港元股份回购